• Je něco špatně v tomto záznamu ?

Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate

P. Melenovská, J. Kopecká, J. Krijt, A. Hnízda, K. Raková, M. Janošík, B. Wilcken, V. Kožich,

. 2015 ; 38 (2) : 287-94. [pub] 20141021

Jazyk angličtina Země Nizozemsko

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010716
E-zdroje Online Plný text

NLK ProQuest Central od 1999-02-01 do 2018-11-30
Medline Complete (EBSCOhost) od 2009-08-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1999-02-01 do 2018-11-30

Classical homocystinuria is caused by mutations in the cystathionine β-synthase (CBS) gene. Previous experiments in bacterial and yeast cells showed that many mutant CBS enzymes misfold and that chemical chaperones enable proper folding of a number of mutations. In the present study, we tested the extent of misfolding of 27 CBS mutations previously tested in E. coli under the more folding-permissive conditions of mammalian CHO-K1 cells and the ability of chaperones to rescue the conformation of these mutations. Expression of mutations in mammalian cells increased the median activity 16-fold and the amount of tetramers 3.2-fold compared with expression in bacteria. Subsequently, we tested the responses of seven selected mutations to three compounds with chaperone-like activity. Aminooxyacetic acid and 4-phenylbutyric acid exhibited only a weak effect. In contrast, heme arginate substantially increased the formation of mutant CBS protein tetramers (up to sixfold) and rescued catalytic activity (up to ninefold) of five out of seven mutations (p.A114V, p.K102N, p.R125Q, p.R266K, and p.R369C). The greatest effect of heme arginate was observed for the mutation p.R125Q, which is non-responsive to in vivo treatment with vitamin B(6). Moreover, the heme responsiveness of the p.R125Q mutation was confirmed in fibroblasts derived from a patient homozygous for this genetic variant. Based on these data, we propose that a distinct group of heme-responsive CBS mutations may exist and that the heme pocket of CBS may become an important target for designing novel therapies for homocystinuria.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010716
003      
CZ-PrNML
005      
20161104074400.0
007      
ta
008      
160408s2015 ne f 000 0|engg|
009      
AR
024    7_
$a 10.1007/s10545-014-9781-9 $2 doi
024    7_
$a 10.1007/s10545-014-9781-9 $2 doi
035    __
$a (PubMed)25331909
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Melenovská, Petra $u Institute of Inherited Metabolic Disorders, Charles University in Prague-First Faculty of Medicine and General University Hospital in Prague, Ke Karlovu 2, 128 08, Praha 2, Czech Republic.
245    10
$a Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate / $c P. Melenovská, J. Kopecká, J. Krijt, A. Hnízda, K. Raková, M. Janošík, B. Wilcken, V. Kožich,
520    9_
$a Classical homocystinuria is caused by mutations in the cystathionine β-synthase (CBS) gene. Previous experiments in bacterial and yeast cells showed that many mutant CBS enzymes misfold and that chemical chaperones enable proper folding of a number of mutations. In the present study, we tested the extent of misfolding of 27 CBS mutations previously tested in E. coli under the more folding-permissive conditions of mammalian CHO-K1 cells and the ability of chaperones to rescue the conformation of these mutations. Expression of mutations in mammalian cells increased the median activity 16-fold and the amount of tetramers 3.2-fold compared with expression in bacteria. Subsequently, we tested the responses of seven selected mutations to three compounds with chaperone-like activity. Aminooxyacetic acid and 4-phenylbutyric acid exhibited only a weak effect. In contrast, heme arginate substantially increased the formation of mutant CBS protein tetramers (up to sixfold) and rescued catalytic activity (up to ninefold) of five out of seven mutations (p.A114V, p.K102N, p.R125Q, p.R266K, and p.R369C). The greatest effect of heme arginate was observed for the mutation p.R125Q, which is non-responsive to in vivo treatment with vitamin B(6). Moreover, the heme responsiveness of the p.R125Q mutation was confirmed in fibroblasts derived from a patient homozygous for this genetic variant. Based on these data, we propose that a distinct group of heme-responsive CBS mutations may exist and that the heme pocket of CBS may become an important target for designing novel therapies for homocystinuria.
650    _2
$a zvířata $7 D000818
650    _2
$a arginin $x farmakologie $7 D001120
650    _2
$a CHO buňky $7 D016466
650    _2
$a katalytická doména $7 D020134
650    _2
$a Cricetulus $7 D003412
650    _2
$a cystathionin-beta-synthasa $x genetika $x metabolismus $7 D003541
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibroblasty $x účinky léků $x enzymologie $7 D005347
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a hem $x farmakologie $7 D006418
650    _2
$a homocystinurie $x diagnóza $x farmakoterapie $x enzymologie $x genetika $7 D006712
650    _2
$a homozygot $7 D006720
650    _2
$a lidé $7 D006801
650    _2
$a molekulární modely $7 D008958
650    _2
$a molekulární chaperony $x farmakologie $7 D018832
650    12
$a mutace $7 D009154
650    _2
$a fenotyp $7 D010641
650    _2
$a konformace proteinů $7 D011487
650    _2
$a sbalování proteinů $7 D017510
650    _2
$a poruchy proteostázy $x diagnóza $x farmakoterapie $x enzymologie $x genetika $7 D057165
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a substrátová specifita $7 D013379
650    _2
$a transfekce $7 D014162
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kopecká, Jana
700    1_
$a Krijt, Jakub
700    1_
$a Hnízda, Aleš $7 xx0207773
700    1_
$a Raková, Kateřina
700    1_
$a Janošík, Miroslav
700    1_
$a Wilcken, Bridget
700    1_
$a Kožich, Viktor
773    0_
$w MED00002747 $t Journal of inherited metabolic disease $x 1573-2665 $g Roč. 38, č. 2 (2015), s. 287-94
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25331909 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20161104074329 $b ABA008
999    __
$a ok $b bmc $g 1114145 $s 935084
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 38 $c 2 $d 287-94 $e 20141021 $i 1573-2665 $m Journal of inherited metabolic disease $n J Inherit Metab Dis $x MED00002747
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...